HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial.

AuthorsTom Wilkinson
JournalThe Lancet. Respiratory medicine (Lancet Respir Med) Vol. 9 Issue 12 Pg. 1344-1345 (12 2021) ISSN: 2213-2619 [Electronic] England
PMID34672951 (Publication Type: Journal Article, Comment)
Chemical References
  • Antiviral Agents
  • Interferon beta-1a
Topics
  • Antiviral Agents (therapeutic use)
  • COVID-19
  • Humans
  • Interferon beta-1a
  • SARS-CoV-2
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: